Earnings Summary

Pacific Biosciences of California, Inc.’s revenue jumped 85.9% since last year same period to $29Mn in the Q1 2021. On a quarterly growth basis, Pacific Biosciences of California, Inc. has generated 6.86% jump in its revenue since last 3-months.

Pacific Biosciences of California, Inc.’s net profit fell -7028.29% since last year same period to $-87.44Mn in the Q1 2021. On a quarterly growth basis, Pacific Biosciences of California, Inc. has generated -216.68% fall in its net profits since last 3-months.

Pacific Biosciences of California, Inc.’s net profit margin fell -3826.85% since last year same period to -301.53% in the Q1 2021. On a quarterly growth basis, Pacific Biosciences of California, Inc. has generated -209.19% fall in its net profit margins since last 3-months.

Pacific Biosciences of California, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.35 - a -6.06% fall from last quarter’s estimates.

Pacific Biosciences of California, Inc.’s earning per share (EPS) estimates for the current year stand at -0.35.

Pacific Biosciences of California, Inc.’s earning per share (EPS) fell -525% since last year same period to -0.34 in the Q3 2022. This indicates that the Pacific Biosciences of California, Inc. has generated -525% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Pacific Biosciences of California, Inc.’s return on assets (ROA) stands at -0.09.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Pacific Biosciences of California, Inc.’s return on equity (ROE) stands at -0.41.